Skip to main content
Signal8

Syra Health Corp (SYRA)

Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.

Sector: Services-Employment Agencies

Industry: Medical - Care Facilities

Syra Health Corp. Class A Common Stock logo

Syra Health Corp. Class A Common Stock

OTC:SYRAHealthcare
-20.59%$0.5711
CLOSED
Mkt Cap$8.11M
EV$6.64M
Float7.52M
O/S13.85M
VOL202K sh
$ Vol$113K
RVOL5.49×
Inst Own-
SI7.6%
Net Cash/Sh+$0.11
EarningsNov 18 · Today
Dilution
Syra Health Corp. Class A Common Stock logoOTC:SYRAClosed$0.5711-20.59%
Financials Summary
Revenue$7.23M
Net Income-$896K
Total Assets$2.77M
Free Cash Flow-$448K
Debt & Equity
Debt 6%
Equity 94%
Total Debt$144K
Total Equity$2.1M
Shares Outstanding
Short Interest

No short interest data available.

Split History

No splits on record

Nothing in SYRA's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$2.77M
Liabilities$675K
Accounts Receivable$918K
Accounts Payable$320K
Inventory$0
PP&E (Net)$34K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$7.23M$7.98M$5.52M$5.62M$1.41M$0
YoY Growth-9.5%44.7%-1.8%298.4%--
Cost of Revenue$4.74M$6.33M$4.11M$4.56M$980K$0
Gross Profit$2.49M$1.65M$1.41M$1.06M$430K$0
Gross Margin34.4%20.7%25.5%18.9%30.5%-
Research and Development$68K$585K$240K$0$0$0
Selling, General, and Administrative$3.3M$1.45M$4.01M$3.11M$416K$4K
Other$20K$3.39M$52K$46K$18K$0
Total Operating Expenses$3.39M$5.42M$4.3M$3.15M$434K$4K
Operating Income (EBIT)-$904K-$3.76M-$2.89M-$2.09M-$3K-$4K
Operating Margin-12.5%-47.2%-52.4%-37.2%-0.2%-
Interest Expense$13K$16K$54K$29K$0$0
Interest Income$21K$21K$3K$63$0$0
Other Income (Expense)$8K$6K-$51K-$28K$0$0
Income Before Tax (EBT)-$896K-$3.76M-$2.94M-$2.12M-$3K-$4K
Income Tax Expense$0$0$0$0$0$0
Net Income-$896K-$3.76M-$2.94M-$2.12M-$3K-$4K
Net Income Margin-12.4%-47.1%-53.3%-37.7%-0.2%-
Supplementary Data
EPS-0.08-0.52-0.60-0.36-0.00-0.00
Diluted EPS-0.08-0.52-0.60-0.29-0.00-0.00
Weighted Average OS11.85M7.26M4.88M5.86M7.28M5.98M
EBITDA-$863K-$3.68M-$2.84M-$2.07M-$3K-$4K
EBITDA Margin-11.9%-46.1%-51.4%-36.9%-0.2%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Assets
Current Assets
Cash and Cash Equivalents$1.61M$2.4M$3.28M$3K$100K$3K
Short-Term Investments$0$0$0$0$0$0
Cash and Short-Term Investments$1.61M$2.4M$3.28M$3K$100K$3K
Accounts Receivable$918K$681K$1.18M$1.35M$282K$0
Inventory$0$0$0$47K$0$0
Other Current Assets$205K$277K$0-$17K$0$0
Total Current Assets$2.74M$3.35M$4.78M$1.43M$382K$3K
Long-Term Assets
Property, Plant & Equipment Net$34K$326K$142K$297K$155K$0
Goodwill$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$596K$0$0
Total Long-Term Assets$34K$326K$142K$893K$155K$0
Other Assets$0$1K$0$0$0$0
Total Assets$2.77M$3.68M$4.92M$2.32M$537K$3K
Liabilities
Current Liabilities
Accounts Payable$320K$102K$463K$436K$126K$0
Short-Term Debt$116K$153K$185K$751K$194K$3K
Current Income Tax Payable$0$0$0$19K$0$0
Current Unearned Revenue$17K$17K$0$0$0$0
Other Current Liabilities$0$0$50K$8K-$194K-$3K
Total Current Liabilities$675K$614K$910K$1.55M$452K$7K
Long-Term Liabilities
Long-Term Debt$0$187K$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0
Total Long-Term Liabilities$0$187K$0$63K$92K$0
Other Liabilities$0$0$0$0$0$0
Total Liabilities$675K$801K$910K$1.61M$544K$7K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0
Common Stock$13K$10K$6K$4K$1K$1K
Retained Earnings-$9.72M-$8.82M-$5.06M-$2.13M-$8K-$5K
Comprehensive Income & Other$0$0$0$0$0$0
Other Stockholders' Equity$11.81M$11.69M$9.07M$2.83M$300$0
Total Equity$2.1M$2.88M$4.01M$710K-$7K-$4K
Minority Interest$0$0$0$0$0$0
Total Liabilities and Equity$2.77M$3.68M$4.92M$2.32M$537K$3K
Supplementary Data
Total Debt$144K$452K$248K$935K$343K$3K
Net Debt-$1.47M-$1.94M-$3.03M$931K$243K$0
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating Activities
Net Income-$896K-$3.76M-$2.94M-$2.12M-$3K-$51K
Depreciation & Amortization$20K$63K$49K$15K$207$0
Deferred Income Tax$0$0$0$0$0$0
Stock-Based Compensation$99K$60K$33K$3K$0$1K
Changes in Working Capital:
  Accounts Receivable-$238K$430K-$110K-$940K-$261K$0
  Inventory$0$0$0$0$0$0
  Accounts Payable$218K-$361K$27K$310K$126K$0
  Other Working Capital$347K$475K$59K-$133K$23K$50K
Total Working Capital Change$327K$544K-$23K-$763K-$112K$50K
Other Non-Cash Items$3K$161K$121K$620K$27K$0
Net Cash from Operating-$448K-$2.93M-$2.76M-$2.24M-$88K$0
Investing Activities
Capital Expenditures-$107-$11K-$15K-$121K-$6K$0
Acquisitions$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0
Net Cash from Investing-$107-$11K-$15K-$121K-$6K$0
Financing Activities
Debt Repaid---$1.46M--$300-
Common Stock Issuance$15K$2.47M$5.33M$2.32M$300$0
Common Stock Repurchases$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0
Other Financing Activities$0$0$200K-$790K$191K$36K
Net Cash from Financing-$333K$2.06M$6.05M$2.27M$192K$36K
Forex Effect$0$0$0$0$0$0
Net Change in Cash-$781K-$885K$3.28M-$97K$97K$36K
Supplementary Data
Operating Cash Flow-$448K-$2.93M-$2.76M-$2.24M-$88K$0
Capital Expenditure-$107-$11K-$15K-$121K-$6K$0
Free Cash Flow-$448K-$2.94M-$2.77M-$2.37M-$94K$0
Cash at Beginning$2.4M$3.28M$3K$100K$3K$0
Cash at End$1.61M$2.4M$3.28M$3K$100K$36K